Castle BiosciencesCSTL
那斯達克 · USD
14.65
-0.50
(-3.30%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Castle BiosciencesCSTL
14.65
-0.50
(-3.30%)
財務數據
損益表
- 0.38
- 0.42
- 0.50
- 0.61
- 0.66
- 0.73
- 0.87
- 0.86
- 0.86
- 0.88
- 3.59
- 9.65
- 19.27
- 22.65
- 7.52
- 10.37
- 19.22
- -1.40
- 0.62
- 1.94
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 87,988 | 86,311 | 85,782 | 87,002 | 72,974 | 66,120 | 61,493 | 50,138 | 42,037 | 38,338 |
營業成本 | 16,383 | 16,183 | 15,609 | 14,519 | 13,894 | 12,423 | 11,319 | 11,058 | 10,182 | 9,520 |
營業毛利 | 71,605 | 70,128 | 70,173 | 72,483 | 59,080 | 53,697 | 50,174 | 39,080 | 31,855 | 28,818 |
營業費用 | - | - | - | - | - | 59,355 | 59,814 | 60,237 | 63,377 | 51,650 |
研發費用 | 12,588 | 11,773 | 12,323 | 14,136 | 13,809 | 12,994 | 12,923 | 13,308 | 14,393 | 11,309 |
推銷及管理費用 | 58,620 | 49,965 | 50,499 | 51,088 | 48,495 | 44,090 | 44,619 | 44,681 | 46,762 | 38,126 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 28,325 | 4,340 | 2,272 | 2,247 | 2,247 | 2,271 | 2,272 | 2,248 | 2,222 | 2,215 |
營業利益 | -27,928 | 4,050 | 5,079 | 5,012 | -5,471 | -5,658 | -9,640 | -21,157 | -31,522 | -22,832 |
其他收入及費用 | 1,674 | 3,927 | 3,404 | 3,144 | 2,996 | 3,119 | 2,769 | 2,399 | 2,336 | 2,275 |
利息費用 | 17 | 92 | 201 | 270 | 14 | 2 | 2 | 3 | 4 | 4 |
稅前純益 | -26,271 | 7,885 | 8,282 | 7,886 | -2,489 | -2,541 | -6,873 | -18,761 | -29,190 | -20,561 |
所得稅 | -423 | -1,705 | 6,013 | -1,034 | 45 | 39 | 32 | 16 | 14 | 57 |
稅後純益 | -25,848 | 9,590 | 2,269 | 8,920 | -2,534 | -2,580 | -6,905 | -18,777 | -29,204 | -20,618 |
基本每股稅後盈餘(元) | -0.90 | 0.34 | 0.08 | 0.32 | -0.09 | - | -0.26 | -0.70 | -1.10 | -0.78 |
稀釋每股稅後盈餘(元) | -0.90 | 0.32 | 0.08 | 0.31 | -0.09 | -0.09 | -0.25 | -0.70 | -1.10 | -0.79 |
基本平均股數(千股) | 28609.00 | 28126.00 | 27840.00 | 27646.00 | 27485.00 | - | 26834.00 | 26733.00 | 26607.00 | 26400.00 |
稀釋平均股數(千股) | 28609.00 | 30200.00 | 29401.00 | 28738.00 | 27485.00 | - | 26834.00 | 26733.00 | 26607.00 | 26400.00 |
還原基本每股稅後盈餘(元) | -0.90 | 0.34 | 0.08 | 0.32 | -0.09 | - | -0.26 | -0.70 | -1.10 | -0.78 |
還原稀釋每股稅後盈餘(元) | -0.90 | 0.32 | 0.08 | 0.31 | -0.09 | -0.09 | -0.25 | -0.70 | -1.10 | -0.79 |
還原基本平均股數(千股) | 28,609 | 28,126 | 27,840 | 27,646 | 27,485 | - | 26,834 | 26,733 | 26,607 | 26,400 |
還原稀釋平均股數(千股) | 28,609 | 30,200 | 29,401 | 28,738 | 27,485 | - | 26,834 | 26,733 | 26,607 | 26,400 |
EBITDA(千元) | 2,075 | 12,132 | 10,374 | 9,781 | -834 | -955 | -5,266 | -16,771 | -27,523 | -18,900 |